SMALL CELL LUNG CANCER
Clinical trials for SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer drug trial halted early
Disease control TerminatedThis early-phase study tested a new drug called INCB099318 in 105 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety and how the body processes it. The study was terminated early, so results are limit…
Matched conditions: SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 17, 2026 02:05 UTC
-
New pill shows promise against Hard-to-Treat cancers
Disease control TerminatedThis early-phase study tested a new daily pill, NKT3447, in 23 adults with advanced solid tumors (like ovarian, endometrial, or lung cancer) that had stopped responding to standard treatments. The goal was to check safety and find the right dose. The study was stopped early, so r…
Matched conditions: SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 02:00 UTC
-
Experimental cancer drug trial halted early – what we know
Disease control TerminatedThis study tested an experimental drug called vobramitamab duocarmazine in people with advanced prostate cancer and other solid tumors that had stopped responding to standard treatments. The goal was to see if the drug could shrink tumors or delay cancer growth. The trial was ter…
Matched conditions: SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: MacroGenics • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Lung cancer combo trial halted: did chest radiation boost survival?
Disease control TerminatedThis study looked at whether adding chest radiation to standard immunotherapy (durvalumab) and chemotherapy could help people with extensive-stage small-cell lung cancer live longer. The trial planned to include 239 adults with good overall health and measurable tumors in the che…
Matched conditions: SMALL CELL LUNG CANCER
Phase: PHASE3 • Sponsor: Norwegian University of Science and Technology • Aim: Disease control
Last updated May 06, 2026 16:02 UTC
-
New drug combo tested for tough cancers
Disease control TerminatedThis early-stage study tested a new drug called SO-C101, either alone or with another drug (pembrolizumab), in 115 people with advanced solid tumors like lung, kidney, or skin cancer. The main goal was to check safety and find the right dose. The study was stopped early, so resul…
Matched conditions: SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: SOTIO Biotech AG • Aim: Disease control
Last updated May 01, 2026 15:58 UTC